Currents12h ago
ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis
From the publisher
/PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection,...
The source's own excerpt, unedited
Discussion
Talk through this story with your campus.
No comments yet.
Be the first to share your take.